Why the study?
Does intramyocardial injection of adipose tissue-derived stem cells with biopolymers improve cell retention and cardiac function in a rat model of myocardial infarction?
Does intramyocardial injection of adipose tissue-derived stem cells with biopolymers improve cell retention and cardiac function in a rat model of myocardial infarction?
Co-injection of adipose tissue-derived stem cells with biopolymers (fibrin or collagen) significantly enhances cell retention and preserves ventricular function post-myocardial infarction in a rat model.
Answers are grounded in this paper and cite their sources.
Biopolymer co-injection may enhance ASC retention and function in rodent MI; leaves open clinical translation of augmented cell therapy.
BACKGROUND: Cardiac cell transplantation is compromised by low cell retention and poor graft viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with biopolymers on cell cardiac retention, ventricular morphometry and performance were evaluated in a rat model of myocardial infarction (MI). METHODOLOGY/PRINCIPAL FINDINGS: 99mTc-labeled ASCs (1x10(6) cells) isolated from isogenic Lewis rats were injected 24 hours post-MI using fibrin a, collagen (ASC/C), or culture medium (ASC/M) as vehicle, and cell body distribution was assessed 24 hours later by gamma-emission counting of harvested organs. ASC/F and ASC/C groups retained significantly more cells in the myocardium than ASC/M (13.8+/-2.0 and 26.8+/-2.4% vs. 4.8+/-0.7%, respectively). Then, morphometric and direct cardiac functional parameters were evaluated 4 weeks post-MI cell injection. Left ventricle (LV) perimeter and percentage of interstitial collagen in the spare myocardium were significantly attenuated in all ASC-treated groups compared to the non-treated (NT) and control groups (culture medium, fibrin, or collagen alone). Direct hemodynamic assessment under pharmacological stress showed that stroke volume (SV) and left ventricle end-diastolic pressure were preserved in ASC-treated groups regardless of the vehicle used to deliver ASCs. Stroke work (SW), a global index of cardiac function, improved in ASC/M while it normalized when biopolymers were co-injected with ASCs. A positive correlation was observed between cardiac ASCs retention and preservation of SV and improvement in SW post-MI under hemodynamic stress. CONCLUSIONS: We provided direct evidence that intramyocardial injection of ASCs mitigates the negative cardiac remodeling and preserves ventricular function post-MI in rats and these beneficial effects can be further enhanced by administering co-injection of ASCs with biopolymers.
No takes yet. Share an insight, caveat, or question.
Danoviz et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: